Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05220254
Other study ID # IRB-60253
Secondary ID P30CA124435
Status Completed
Phase N/A
First received
Last updated
Start date October 18, 2021
Est. completion date October 27, 2022

Study information

Verified date November 2023
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date October 27, 2022
Est. primary completion date October 27, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Daily cigarette smoker or some day smoker (>9 cigarettes per week) - Age 18+ - English or Spanish fluent - Smartphone compatibility - Available to interact with a smartphone app for 6-weeks - Available to complete the EOT assessment at end of 6-weeks - Ability to understand and the willingness to personally sign the written IRB-approved informed consent document. - Confirm phone, email, address during consent Exclusion Criteria: - Ever had epilepsy - Less than 10 cigarettes per week - Not English or Spanish fluent - No smartphone compatibility - Unavailable to interact with the VR program, - Unavailable to answer questions about the intervention post-treatment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
MindCotine's VR app
The MindCotine program would be a 6-week intervention to help users utilize mindfulness based skills, and involves virtual exposure therapy.

Locations

Country Name City State
United States Stanford University Palo Alto California

Sponsors (2)

Lead Sponsor Collaborator
Stanford University National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients Who Registered With the MindCotine Application Total number of patients who registered with the app, out of total number of participants who were enrolled (eligible and willing to accept help with quitting). This measure is to assess whether MindCotine is a feasible smoking cessation option among patients who smoke cigarettes. 6 weeks
Primary Number of Patients With Interest in the MindCotine Application Total number of patients who expressed interest in the app, out of total number of participants who were screened for enrollment. This measure is to assess whether MindCotine is a feasible smoking cessation option among patients who smoke cigarettes. 6 weeks
Primary Number of Patients Who Would Recommend the MindCotine Application as a Measure of Feasibility Among Patients Who Smoke. Learning whether MindCotine is a feasible smoking cessation option among patients who smoke cigarettes.
Interest in using the app will be calculated as total number of patients who recommend the app to others.
6 weeks
Secondary Number of Patients Who Attempt to Quit Smoking by Using the Application Measured as the number of participants who had a 24-hour quit attempt in the past 6-weeks prior to end of treatment survey 6 weeks prior to end of treatment survey
Secondary Number of Patients Using Cessation Medication by End of Treatment Number of participants using cessation medications among those who completed the end of treatment survey. 6 weeks
Secondary Number of MindCotine App Program Activities Completed Program activities include VR-MET exercises and guided mindfulness-based two-dimensional video, audio, and reflection exercises. 6 weeks
Secondary Number of MindCotine App Journal Entries Completed Journal Record refers to CBT-based self-reflections. 6 weeks
Secondary Number of MindCotine App Coaching Engagements Completed Coaching Engagement refers to communicating with a coach through the MindCotine mobile application. 6 weeks
Secondary Average Change in Cigarette Use Average change in cigarette use from baseline to end of treatment among patients using the MindCotine app. baseline to end of treatment, up to 6 weeks
Secondary MindCotine Dropout Number of patients who withdrew or were removed from the study. 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT04617444 - The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function N/A
Completed NCT02796391 - Facilitating Smoking Cessation With Reduced Nicotine Cigarettes Phase 2
Completed NCT03397511 - Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City N/A
Not yet recruiting NCT05188287 - A Culturally Tailored Smartphone Application for African American Smokers N/A
Recruiting NCT05264428 - The Effect of Honey on Lessening the Withdrawal Symptoms N/A
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT04133064 - Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study N/A
Completed NCT03187730 - Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants Phase 4
Completed NCT03474783 - To Explore the Factors Affecting the Effectiveness of Smoking Cessation N/A
Completed NCT04635358 - Feasibility Study of Smoking Cessation for the Staff of a Hospital Center N/A
Terminated NCT03670264 - BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation N/A
Not yet recruiting NCT06307496 - VIDeOS for Smoking Cessation N/A
Completed NCT02997657 - Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial N/A
Completed NCT02905656 - Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02239770 - Pharmacokinetics of Nicotine Film in Smokers N/A
Completed NCT02562521 - A Smoking Cessation Intervention for Yale Dining Employees Phase 4
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A